abs164.txt	background		prostate	cancer	survivors	who	receive	androgen	deprivation	therapy(adt)	are	at	increased	risk	of	cardiovascular	disease		they	require	coordinatedcare	between	cancer	specialist	and	primary	care	physicians	(pcps)	to	monitor	forcancer	control	and	manage	cardiovascular	risk	factors	methods		we	prospectively	enrolled	103	men	receiving	adt	with	radiotherapy	from	7institutions	to	assess	cardiovascular	risk	factors	and	survivorship	care		medicalrecords		fasting	labs		and	patient-reported	outcomes	using	a	validated	instrumentwere	assessed	at	baseline	(pre-treatment)	and	1	year	post-rt	results		cardiovascular	disease	(39%)	and	risk	factors	(diabetes	22%	hypertension	63%		hyperlipidemia	31%)	were	prevalent	at	baseline		during	thefirst	year	after	rt	completion		63%	received	cardiovascular	monitoring	concordantwith	american	heart	association	guidelines		fasting	labs	at	1	year	showed	24%with	inadequately	controlled	blood	sugar		and	22%	elevated	cholesterol		patientperceptions	about	care	coordination	were	relatively	low		at	1	year		57%	reportedthat	their	pcp		always	know	about	the	care	i	receive	at	other	places			67%reported	that	their	cancer	physician		communicated	with	other	providers	i	see		and	65%	reported	the	cancer	physician		knows	the	results	of	my	visits	with	otherdoctors		conclusions		prostate	cancer	patients	who	receive	adt	and	rt	are	a	vulnerablepopulation	with	prevalent	baseline	cardiovascular	disease	and	risk	factors		andsuboptimal	survivorship	care	specifically	related	to	coordinated	care	andcardiovascular	monitoring		clinical	trials	examining	ways	to	improve	the	care	andoutcomes	of	these	survivors	are	needed	
